New Products Will Focus on Dogs’ Eyes, Ears and Overall Wellbeing

VAUGHAN, ON , Oct. 24, 2022 /PRNewswire/ — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the introduction of Project Watson health care products for dogs in the particular United States . The new line of products is specifically formulated to help support dogs’ eyes, ears plus overall wellbeing using high quality and naturally inspired ingredients.  

“For nearly two centuries, Bausch + Lomb has been associated with many of the most significant advances in eye health. Building on our eye care expertise plus history in surgical solutions for veterinarians, we created Project Watson to help address the particular unmet wellness care needs of canines, ” said Joe Gordon , president, Global Consumer, Surgical and Vision Care, Bausch + Lomb. “Developed in collaboration with veterinarians, Project Watson focuses on dogs’ eye and ears – important areas that are often overlooked in the health of our beloved four-legged family members. Project Watson products will begin rolling out online in certain retailers beginning next month. ”

The full line of Project Watson items includes:

  • Task Watson vision wash with regard to dogs — a gentle, pH-balanced multi-purpose solution developed to assist cleanse irritants and debris from dogs’ eyes
  • Project Watson eyelid wipes for dogs –  gentle, pH-balanced, pre-moistened textured baby wipes with micellar technology that cleanses plus hydrates around the eye to help remove excess buildup
  • Project Watson ear wash for canines – a gentle, pH-balanced cleansing solution formulated to help assistance cleaning and care to help keep ears healthy
  • Project Watson ear wipes regarding dogs : gentle, pH-balanced pre-moistened textured wipes formulated to assist support hearing cleaning plus treatment
  • Project Watson eye health supplement intended for dogs + tear stain support – a daily chewable supplement with seven active ingredients in order to help promote eye health and help reduce tear stains in dogs, from the inside out
  • Project Watson eye + multi-health product – the daily chewable formulated with nine ingredients to help support key areas of a dog’s wellness: eyes, joints, skin, heart and immune system

“Grooming care for dogs frequently includes nail trims and haircuts, but regular attention and ear canal maintenance is also necessary. Without regular eye and ear cleaning, there is the potential to get skin irritation and infections among other issues, inch said Danielle Rutherford , VMD, Westside Veterinary Center, New York . “I look forward to having access to this new dedicated type of products for canines and their pet owners. inches

Project Watson products are manufactured plus packaged within recyclable containers at U. S. Food and Drug Administration-registered facilities in the United States using U. S. and imported ingredients. The eye wash and two supplements will be available online starting in November 2022 at  Chewy, Walmart, PetSmart plus Amazon. The particular remaining three products will be available by the end of the year.

For more information on Task Watson, please visit .

Project Watson and Bausch + Lomb’s Commitment in order to Pet Treatment

Shortly after Watson , a terrier mix, was rescued, his parents found it difficult to find items to assist protect his eyes and ear from discomfort and excess build-up. Luckily, Watson’s dad is an employee of Bausch + Lomb, a leader inside human eye care, and together they realized there was an opportunity to help all dogs who have similar issues. This led in order to the development of Project Watson health care products for dogs that are usually specifically formulated along with the same expert treatment and unwavering quality as all some other products in the Bausch + Lomb portfolio. With the availability associated with Project Watson products within the United States , Bausch + Lomb will be focused on ensuring canines can receive the care they need.

Project Watson builds on the company’s history in pet care, which began in 2015 when Bausch + Lomb acquired Acrivet, the particular veterinary division of S& V Technologies GmbH. Today Bausch + Lomb Veterinary solutions provides veterinarians with intraocular lenses, viscoelastics, surgical instruments, bandage and corrective contact lens and more. Visit pertaining to more info.  

About Bausch + Lomb

Bausch + Lomb is devoted to protecting and enhancing the gift of sight around the world – from the particular moment of birth through every phase of life. Its comprehensive portfolio of more than 400 items includes contact lenses, lens care products, eye maintenance systems, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic medical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research plus development, manufacturing and commercial footprint with more than 12, 000 employees and a presence inside nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario along with corporate offices in Bridgewater, New Jersey . With regard to more details, visit   and connect with us on Twitter , LinkedIn , Facebook and Instagram .

Forward-looking Statements

This particular news release may contain forward-looking statements, which usually may generally be identified by the use associated with the words “anticipates, ” “hopes, ” “expects, ” “intends, ” “plans, ” “should, ” “could, ” “would, ” “may, ” “believes, ” “estimates, ” “potential, ” “target, ” or “continue” plus variations or even similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the particular forward-looking statements. These risks and questions include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb’s filings with the U. H. Securities plus Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited in order to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that will pandemic and its potential effects, the severity, duration plus future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact upon Bausch + Lomb, including but not limited to its project development timelines, launches and costs (which might increase). Readers are cautioned not in order to place undue reliance on any of these forward-looking statements. These forward-looking claims speak only as of the particular date hereof. Bausch + Lomb undertakes no obligation to update some of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Task Watson is a   trademark of Bausch & Lomb Incorporated or even its affiliates.
Any other product/brand names and/or logos are trademarks of the respective owners.
© 2022 Bausch & Lomb Incorporated or its affiliate marketers.
PWR. 0012. USA. 22

Investor Contacts:                                                          

Media Contacts:

Arthur Shannon                                                               

Lainie Keller

[email protected]                                        

[email protected]

(908) 927-1198

Allison Ryan                                                                           

[email protected]                                              

Kristy Marks                                           

(877) 354-3705 (toll free)                                               

[email protected]  

(908) 927-0735                                                               

(908) 927-0683

SOURCE Bausch + Lomb Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *